255 related articles for article (PubMed ID: 21889487)
21. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
22. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
[TBL] [Abstract][Full Text] [Related]
23. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
24. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
25. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
[TBL] [Abstract][Full Text] [Related]
26. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
27. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.
Kuzuya M; Nakamura K; Sasaki T; Cheng XW; Itohara S; Iguchi A
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1120-5. PubMed ID: 16556856
[TBL] [Abstract][Full Text] [Related]
28. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway.
Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ
Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
[TBL] [Abstract][Full Text] [Related]
31. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
32. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
Canault M; Peiretti F; Poggi M; Mueller C; Kopp F; Bonardo B; Bastelica D; Nicolay A; Alessi MC; Nalbone G
J Pathol; 2008 Apr; 214(5):574-83. PubMed ID: 18247429
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
Deguchi JO; Aikawa E; Libby P; Vachon JR; Inada M; Krane SM; Whittaker P; Aikawa M
Circulation; 2005 Oct; 112(17):2708-15. PubMed ID: 16230484
[TBL] [Abstract][Full Text] [Related]
34. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone promotes atherosclerotic plaque stability in fat-fed ApoE-knockout mice.
Zhou M; Xu H; Pan L; Wen J; Liao W; Chen K
Eur J Pharmacol; 2008 Aug; 590(1-3):297-302. PubMed ID: 18602628
[TBL] [Abstract][Full Text] [Related]
37. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
[TBL] [Abstract][Full Text] [Related]
38. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice.
Moura R; Tjwa M; Vandervoort P; Van Kerckhoven S; Holvoet P; Hoylaerts MF
Circ Res; 2008 Nov; 103(10):1181-9. PubMed ID: 18818405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
